NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Delox

Delox

Private
CascaisHealthcare & Life Scienceshttps://delox-global.com/

Last Round

Series A

Jan 1, 2026

Total Funding Raised

$4.89M

Company Overview

Delox is a healthtech company that develops advanced bio-decontamination systems utilizing a proprietary solid hydrogen peroxide formulation to eliminate microorganisms in controlled environments.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

bio-decontaminationhydrogen peroxide decontaminationVPHPvaporized hydrogen peroxidesterilization equipmentbiosafety cabinet decontaminationcleanroom decontaminationbiotech equipmentlaboratory safetycontamination controldeconsolid-state hydrogen peroxidebiodeconmedical devicepreventive maintenance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Delox Comps

Public and private peers based on sector, stage, and business model.

Delox comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Delox Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 1, 2026
GrantNov 1, 2023
VC RoundNov 1, 2023
SeedMay 18, 2022
GrantMay 3, 2021

Key People

Founding team and executive leadership

Fernando Antunes

CTO and Co-Founder

Founding Team

Fadhil Musa

CEO, Co-Promotor

Executive Team

Delox Investors

Notable investors and investment history

Delox investors
InvestorRounds
European Innovation Council FundSeries A, Grant
Caixa CapitalSeed, Series A, Pre Seed
Kiilto VenturesSeed
Bionova CapitalSeed, Pre Seed
Beta CapitalSeries A
EIC FundVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2021

    Secured $310K in grant funding.

Delox Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Delox Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Delox's valuation, stock price, and market status.

Firmographic Details

HeadquartersCascais
Employee Range14
Year Founded2018
Last FundingJan 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.